Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 392,218 | 227,909 | 172,590 | 225,508 | 282,092 |
| Cost of Goods | -195,089 | 393,335 | 99,606 | 122,918 | 167,322 |
| Gross Profit | 587,307 | -165,426 | 72,984 | 102,590 | 114,770 |
| Operating Expenses | 72,061 | 107,537 | 69,189 | 65,557 | 84,288 |
| Operating Income | 515,157 | -272,628 | 4,401 | 37,951 | 30,804 |
| Interest Expense | 27,409 | 11,089 | 8,454 | 8,331 | 7,116 |
| Other Income | 32,385 | -151 | 103 | -47,114 | -10,399 |
| Pre-tax Income | 520,133 | -283,868 | -3,950 | -17,494 | 13,289 |
| Income Tax | 118,261 | -104,531 | -1,249 | -7,086 | 1,862 |
| Net Income Continuous | 401,872 | -179,337 | -2,701 | -10,408 | 11,427 |
| Net Income | $399,824 | $-179,337 | $-2,701 | $-10,408 | $11,427 |
| EPS Basic Total Ops | N/A | -2.51 | -0.04 | -0.15 | 0.17 |
| EPS Basic Continuous Ops | N/A | -2.51 | -0.04 | -0.15 | 0.17 |
| EPS Diluted Total Ops | N/A | -2.51 | -0.04 | -0.15 | 0.17 |
| EPS Diluted Continuous Ops | N/A | -2.51 | -0.04 | -0.15 | 0.17 |
| EBITDA(a) | $488,127 | $-245,946 | $25,100 | $53,671 | $50,777 |